Work in progress: transcatheter management of primary carcinoma of the liver.
Authors:
- C CharnsangavejCCC Charnsangavej
- V P ChuangVCV P Chuang
- S WallaceSWS Wallace
- C S SooCSC S Soo
- T BowersTBT Bowers
- 1 April 1983
- journal article
- research article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 147 (1) , 51-55
Abstract
Twenty-four patients with hepatocellular carcinoma or cholangiocarcinoma were treated with hepatic artery infusion (HAI) of chemotherapeutic agents (14 patients) or hepatic artery embolization (HAE) (11 patients). One patient had a combination of the two treatments. Ten of the 14 (71%) patients who underwent HAI demonstrated partial remission. The median survival time was 12.3 months. Six of the 9 patients (67%) who underwent HAE and for whom follow-up was available responded to treatment. The median survival time for those patients was 17.4 months.Keywords
This publication has 2 references indexed in Scilit:
- Hepatic artery embolization in the treatment of hepatic neoplasms.Radiology, 1981
- Ivalon embolization in abdominal neoplasmsAmerican Journal of Roentgenology, 1981